Cafeine to prevent Alzheimer disease?
The Dr Thibaud Lebouvier, neurologist at the Memory Center of the Lille University Hospital has received a grant to conduct the CAFCA clinical trial. This clinical trial aims to measure the capacity of coffee (more precisely cafeine) to slow down/prevent the symptoms of Alzheimer disease.
This project is in collaboration with Dr David Blum of the “Alzheimer and Tauopathy” team of the JP AUbert Research center in Lille
